Industry News
Pharmaceutical Industry News
COVID-19 tracker: Moderna seeks dismissal in Alnylam patent case
COVID-19 tracker: Moderna seeks dismissal in Alnylam patent case zbecker Wed, 04/13/2022 - 14:42
COVID-19 tracker: Novavax, pushing for emergency vaccine nod, targets mRNA skeptics
COVID-19 tracker: Novavax, pushing for emergency vaccine nod, targets mRNA skeptics zbecker Wed, 04/13/2022 - 14:42
COVID-19 tracker: Moderna doses headed for Swiss scrapheap, patient group calls for official booster schedule
COVID-19 tracker: Moderna doses headed for Swiss scrapheap, patient group calls for official booster schedule zbecker Wed, 04/13/2022 - 14:42
COVID-19 tracker: Patients successfully treated with Pfizer’s Paxlovid may rebound later; Clover advances omicron shot
COVID-19 tracker: Patients successfully treated with Pfizer's Paxlovid may rebound later; Clover advances omicron shot zbecker Wed, 04/13/2022 - 14:42
COVID-19 tracker: Moderna to take over vaccine marketing duties in Japan
COVID-19 tracker: Moderna to take over vaccine marketing duties in Japan zbecker Wed, 04/13/2022 - 14:42
COVID-19 tracker: Pfizer, with new vaccine R&D chief inbound, petitions FDA for third dose in young kids
COVID-19 tracker: Pfizer, with new vaccine R&D chief inbound, petitions FDA for third dose in young kids zbecker Wed, 04/13/2022 - 14:42
Fighting the Latest Efforts to Outlaw Abortion
Readers discuss moves to ban abortion pills and lament passage of an Oklahoma anti-abortion bill. Also: Saving baseball; sex and manners; Covid vaccines.
AbbVie president Severino departs to help pilot Flagship Pioneering
AbbVie president Severino departs to help pilot Flagship Pioneering fkansteiner Wed, 04/13/2022 - 11:26
Amgen parts ways with part of Ventura County headquarters campus: report
Amgen parts ways with part of Ventura County headquarters campus: report zbecker Wed, 04/13/2022 - 10:44
J&J, 2-stepping through talc litigation, faces fresh claims it hid worker’s asbestos exposure
J&J, 2-stepping through talc litigation, faces fresh claims it hid worker's asbestos exposure fkansteiner Wed, 04/13/2022 - 10:23
J&J, Roche partner Halozyme buys Antares Pharma for $1B, beefing up drug delivery offerings
J&J, Roche partner Halozyme buys Antares Pharma for $1B, beefing up drug delivery offerings aliu Wed, 04/13/2022 - 09:53
With recent notices of ‘deficiencies,’ the FDA may be ‘raising the regulatory bar’: analyst
With recent notices of 'deficiencies,' the FDA may be 'raising the regulatory bar': analyst kdunleavy Wed, 04/13/2022 - 09:35
The mysterious case of Viatris and the missing insulin label deepens
The mysterious case of Viatris and the missing insulin label deepens fkansteiner Wed, 04/13/2022 - 08:46
Bristol Myers Squibb’s aging Orencia finds new life with rheumatologists as they shun newer JAK drugs from Pfizer, AbbVie: report
Bristol Myers Squibb's aging Orencia finds new life with rheumatologists as they shun newer JAK drugs from Pfizer, AbbVie: report badams Wed, 04/13/2022 - 02:39
FDA slaps another hold on Ocugen, Bharat’s COVID vaccine after WHO flags manufacturing problems
FDA slaps another hold on Ocugen, Bharat's COVID vaccine after WHO flags manufacturing problems kdunleavy Tue, 04/12/2022 - 16:11
AACR: Novartis aims to keep canakinumab’s early lung cancer hopes alive despite metastatic failure
AACR: Novartis aims to keep canakinumab's early lung cancer hopes alive despite metastatic failure aliu Tue, 04/12/2022 - 11:24
Myovant, Pfizer’s expansion bid for Myfembree hits a snag at the FDA
Myovant, Pfizer's expansion bid for Myfembree hits a snag at the FDA kdunleavy Tue, 04/12/2022 - 09:38
Novartis’ global revamp to cost thousands of jobs for simpler structures: report
Novartis' global revamp to cost thousands of jobs for simpler structures: report aliu Tue, 04/12/2022 - 09:25
Pfizer’s COVID pill Paxlovid gets boost in Britain thanks to spot in national trial
Pfizer's COVID pill Paxlovid gets boost in Britain thanks to spot in national trial fkansteiner Tue, 04/12/2022 - 09:02
BioNTech sets sights on oral mRNA vaccines with deal to access Matinas delivery technology
BioNTech sets sights on oral mRNA vaccines with deal to access Matinas delivery technology ntaylor Tue, 04/12/2022 - 07:57